JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anders, R. A.
Right arrow Articles by Leof, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anders, R. A.
Right arrow Articles by Leof, E. B.

Volume 271, Number 36, Issue of September 6, 1996 pp. 21758-21766
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Chimeric Granulocyte/Macrophage Colony-stimulating Factor/Transforming Growth Factor-beta (TGF-beta ) Receptors Define a Model System for Investigating the Role of Homomeric and Heteromeric Receptors in TGF-beta Signaling

(Received for publication, April 10, 1996, and in revised form, June 7, 1996)

Robert A. Anders and Edward B. Leof

From the Thoracic Research Unit and Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905

Transforming growth factor-beta (TGF-beta ) belongs to a family of ligands that regulate cell growth and differentiation. The most commonly observed receptors are referred to as the type I, type II, and type III (betaglycan) TGF-beta receptors. Two receptor models have been presented to account for the various cellular responses to TGF-beta . The first proposes that all TGF-beta signaling results from the formation of a heteromeric type I/type II complex, while the second suggests that distinct type I or type II TGF-beta receptor combinations mediate aspects of TGF-beta signaling. We have addressed this general question relating to TGF-beta signaling by constructing chimeric receptors consisting of the extracellular domain of the granulocyte/macrophage colony-stimulating factor (GM-CSF) alpha  or beta  receptor fused to the transmembrane and cytoplasmic domain of the type I or type II TGF-beta receptor. Since high affinity GM-CSF binding requires dimerization of the alpha  and beta  ligand binding subunits, the response elicited by defined type I and/or type II TGF-beta receptor cytoplasmic domain homomers or heteromers can be examined. We show in mesenchymal AKR-2B cells that while TGF-beta -dependent transient luciferase activity, endogenous gene activity, and long-term biological responses are similarly induced by activating the chimeric heteromeric receptors with GM-CSF as the endogenous TGF-beta receptor, chimeric homomeric type I/type I or type II/type II receptors are signaling-incompetent.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
S. J. Murphy, K. E. Shapira, Y. I. Henis, and E. B. Leof
A Unique Element in the Cytoplasmic Tail of the Type II Transforming Growth Factor-beta Receptor Controls Basolateral Delivery
Mol. Biol. Cell, October 1, 2007; 18(10): 3788 - 3799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. Wilkes and E. B. Leof
Transforming Growth Factor beta Activation of c-Abl Is Independent of Receptor Internalization and Regulated by Phosphatidylinositol 3-Kinase and PAK2 in Mesenchymal Cultures
J. Biol. Chem., September 22, 2006; 281(38): 27846 - 27854.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Boxall, S. T. Holgate, and D. E. Davies
The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma
Eur. Respir. J., January 1, 2006; 27(1): 208 - 229.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Mitchell, A. Choudhury, R. E. Pagano, and E. B. Leof
Ligand-dependent and -independent Transforming Growth Factor-{beta} Receptor Recycling Regulated by Clathrin-mediated Endocytosis and Rab11
Mol. Biol. Cell, September 1, 2004; 15(9): 4166 - 4178.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. J. Murphy, J. J. E. Dore, M. Edens, R. J. Coffey, J. A. Barnard, H. Mitchell, M. Wilkes, and E. B. Leof
Differential Trafficking of Transforming Growth Factor-{beta} Receptors and Ligand in Polarized Epithelial Cells
Mol. Biol. Cell, June 1, 2004; 15(6): 2853 - 2862.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. C. Wilkes, S. J. Murphy, N. Garamszegi, and E. B. Leof
Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor {beta} Independent of Smad2 and Smad3
Mol. Cell. Biol., December 1, 2003; 23(23): 8878 - 8889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Itoh, M. Thorikay, M. Kowanetz, A. Moustakas, F. Itoh, C.-H. Heldin, and P. ten Dijke
Elucidation of Smad Requirement in Transforming Growth Factor-beta Type I Receptor-induced Responses
J. Biol. Chem., January 31, 2003; 278(6): 3751 - 3761.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. G. Penheiter, H. Mitchell, N. Garamszegi, M. Edens, J. J. E. Dore Jr., and E. B. Leof
Internalization-Dependent and -Independent Requirements for Transforming Growth Factor {beta} Receptor Signaling via the Smad Pathway
Mol. Cell. Biol., July 1, 2002; 22(13): 4750 - 4759.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. S. Seto, H. J. Bellen, and T. E. Lloyd
When cell biology meets development: endocytic regulation of signaling pathways
Genes & Dev., June 1, 2002; 16(11): 1314 - 1336.
[Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Garamszegi, J. J. E. Dore Jr., S. G. Penheiter, M. Edens, D. Yao, and E. B. Leof
Transforming Growth Factor beta Receptor Signaling and Endocytosis Are Linked through a COOH Terminal Activation Motif in the Type I Receptor
Mol. Biol. Cell, September 1, 2001; 12(9): 2881 - 2893.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S.-J. Yong, A. Adlakha, and A. H. Limper
Circulating Transforming Growth Factor-{beta}1 : A Potential Marker of Disease Activity During Idiopathic Pulmonary Fibrosis
Chest, July 1, 2001; 120(2007): 68S - 70S.
[Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. J.E. Doré Jr., D. Yao, M. Edens, N. Garamszegi, E. L. Sholl, and E. B. Leof
Mechanisms of Transforming Growth Factor-{beta} Receptor Endocytosis and Intracellular Sorting Differ between Fibroblasts and Epithelial Cells
Mol. Biol. Cell, March 1, 2001; 12(3): 675 - 684.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Yao, J. J. E. Dore Jr., and E. B. Leof
FKBP12 Is a Negative Regulator of Transforming Growth Factor-beta Receptor Internalization
J. Biol. Chem., April 21, 2000; 275(17): 13149 - 13154.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Gilboa, A. Nohe, T. Geissendörfer, W. Sebald, Y. I. Henis, and P. Knaus
Bone Morphogenetic Protein Receptor Complexes on the Surface of Live Cells: A New Oligomerization Mode for Serine/Threonine Kinase Receptors
Mol. Biol. Cell, March 1, 2000; 11(3): 1023 - 1035.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Herman, C. Bignon, N. Daniel, J. Grosclaude, A. Gertler, and J. Djiane
Functional Heterodimerization of Prolactin and Growth Hormone Receptors by Ovine Placental Lactogen
J. Biol. Chem., February 25, 2000; 275(9): 6295 - 6301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. Zhu and A. M. Sizeland
A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-{beta} Receptor Activation
J. Biol. Chem., April 23, 1999; 274(17): 11773 - 11781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lux, L. Attisano, and D. A. Marchuk
Assignment of Transforming Growth Factor beta 1 and beta 3 and a Third New Ligand to the Type I Receptor ALK-1
J. Biol. Chem., April 9, 1999; 274(15): 9984 - 9992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. G. Wells, L. Gilboa, Y. Sun, X. Liu, Y. I. Henis, and H. F. Lodish
Transforming Growth Factor-beta Induces Formation of a Dithiothreitol-resistant Type I/Type II Receptor Complex in Live Cells
J. Biol. Chem., February 26, 1999; 274(9): 5716 - 5722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. E. Dore Jr., M. Edens, N. Garamszegi, and E. B. Leof
Heteromeric and Homomeric Transforming Growth Factor-beta Receptors Show Distinct Signaling and Endocytic Responses in Epithelial Cells
J. Biol. Chem., November 27, 1998; 273(48): 31770 - 31777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Anders, J. J. E. Dore Jr., S. L. Arline, N. Garamszegi, and E. B. Leof
Differential Requirement for Type I and Type II Transforming Growth Factor beta  Receptor Kinase Activity in Ligand-mediated Receptor Endocytosis
J. Biol. Chem., September 4, 1998; 273(36): 23118 - 23125.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. A. Anders, S. L. Arline, J. J.E. Doré, and E. B. Leof
Distinct Endocytic Responses of Heteromeric and Homomeric Transforming Growth Factor beta  Receptors
Mol. Biol. Cell, November 1, 1997; 8(11): 2133 - 2143.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. Persson, S. Souchelnytskyi, P. Franzen, K. Miyazono, P. ten Dijke, and C.-H. Heldin
Transforming Growth Factor (TGF-beta )-specific Signaling by Chimeric TGF-beta Type II Receptor with Intracellular Domain of Activin Type IIB Receptor
J. Biol. Chem., August 22, 1997; 272(34): 21187 - 21194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.